Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk? (Q36255435)

13 August 2017

1 reference

title

Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk? (English)

1 reference

13 August 2017

Stephan J L Bakker

1

1 reference

13 August 2017

Ron T Gansevoort

2

1 reference

13 August 2017

Erik M Stuveling

3

1 reference

13 August 2017

Rijk O B Gans

4

1 reference

13 August 2017

Dick de Zeeuw

5

1 reference

13 August 2017

publication date

1 October 2005

1 reference

Current Hypertension Reports

13 August 2017

published in

1 reference

13 August 2017

volume

7

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

379-384

1 reference

Prediction of Coronary Heart Disease Using Risk Factor Categories

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11906-005-0075-3

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-005-0075-3

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-005-0075-3

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-005-0075-3

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-005-0075-3

Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11906-005-0075-3

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria

21 January 2018

1 reference

12 December 2020

The effect of weight loss on a stable biomarker of inflammation, C-reactive protein

1 reference

12 December 2020

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

12 December 2020

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

12 December 2020

Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay

1 reference

12 December 2020

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

12 December 2020

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

12 December 2020

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

1 reference

12 December 2020

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

1 reference

12 December 2020

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

12 December 2020

CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers

1 reference

12 December 2020

Microalbuminuria as predictor of increased mortality in elderly people

1 reference

12 December 2020

Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women

1 reference

12 December 2020

Microalbuminuria precedes the development of NIDDM

1 reference

12 December 2020

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

12 December 2020

Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels

1 reference

12 December 2020

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

12 December 2020

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Albuminuria of hypertensive patients

1 reference

12 December 2020

Comparison of the effects of ramipril versus telmisartan in reducing serum levels of high-sensitivity C-reactive protein and oxidized low-density lipoprotein cholesterol in patients with type 2 diabetes mellitus

1 reference

12 December 2020

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

1 reference

12 December 2020

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

1 reference

12 December 2020

Role of hs-CRP measurements in the current cardiovascular risk assessment

1 reference

12 December 2020

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

12 December 2020

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

1 reference

12 December 2020

Effects of aspirin (325 mg/day) on serum high-sensitivity C-reactive protein, cytokines, and adhesion molecules in healthy volunteers

1 reference

12 December 2020

C-reactive protein modifies the relationship between blood pressure and microalbuminuria

1 reference

12 December 2020

Urinary albumin excretion. An independent predictor of ischemic heart disease

1 reference

12 December 2020

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

C-reactive protein levels and outcomes after statin therapy

1 reference

12 December 2020

Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway

1 reference

12 December 2020

Cystatin C and the risk of death and cardiovascular events among elderly persons

1 reference

12 December 2020

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults

1 reference

12 December 2020

Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial

1 reference

12 December 2020

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

1 reference

12 December 2020

Arterial hypertension, microalbuminuria, and risk of ischemic heart disease

1 reference

12 December 2020

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

12 December 2020

Role of endothelial dysfunction in atherosclerosis

1 reference

12 December 2020

Retention of albumin in the circulation is governed by saturable renal cell-mediated processes

1 reference

12 December 2020

Albumin fragments in normal rat urine are derived from rapidly degraded filtered albumin

1 reference

12 December 2020

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

1 reference

12 December 2020

The prognostic significance of proteinuria: the Framingham study

1 reference

12 December 2020

Poor predictive value of high-sensitivity C-reactive protein indicates need for reassessment

1 reference

12 December 2020

Mechanism of albuminuria associated with cardiovascular disease and kidney disease

1 reference

12 December 2020

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

12 December 2020

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

12 December 2020

Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan

1 reference

12 December 2020

Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation

1 reference

12 December 2020

Albuminuria, just a marker for cardiovascular disease, or is it more?

1 reference

12 December 2020

Microalbuminuria predicts mortality in non-insulin-dependent diabetics

1 reference

12 December 2020

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study

1 reference

12 December 2020

World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic

1 reference

12 December 2020

10.1007/S11906-005-0075-3

Identifiers

DOI

1 reference

13 August 2017

1 reference